Hantaan Virus Nephropathy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hantaan Virus Nephropathy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 2

NCT04333459

Safety and Immunogenicity of a Hantaan Virus DNA Vaccine and a Puumala Virus DNA Vaccine, For The Prevention of Hemorrha…

A randomized 4 cohort study that is comparing the data collected during the earlier phase study and to determine if immunogenicity can be retained with a 1 mg d…

United States132 participantsStarted 2021-08-23

Treatment: Hataan DNA Vaccine/Puumala DNA Vaccine